Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT

被引:2
作者
Sodji, Quaovi H. [1 ,2 ]
Harris, Jeremy P. [3 ]
Quon, Andrew [4 ]
Modlin, Leslie A. [1 ]
Lau, Brianna [1 ]
Jiang, Alice [1 ]
Trakul, Nicholas [1 ]
Maxim, Peter G. [3 ]
Diehn, Maximilian [1 ,2 ]
Loo, Billy W., Jr. [1 ,2 ]
Hiniker, Susan M. [1 ,2 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[3] Univ Calif Irvine, Dept Radiat Oncol, Irvine, CA USA
[4] Univ Calif Los Angeles, Dept Nucl Med, Los Angeles, CA USA
关键词
Local recurrence; Non-small cell lung cancer; Positive predictive value; F-18-fluorodeoxyglucose-positron emission tomography; Stereotactic Ablative Radiotherapy; CELL LUNG-CANCER; BODY RADIOTHERAPY; F-18-FDG PET/CT; FIBROSIS; SBRT;
D O I
10.1016/j.cllc.2022.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the performance of FDG-PET-CT in distinguishing between local recurrence vs. post radiation changes in patients with early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy, we performed a retrospective analysis of patients with concerning post-treatment FDG-PET-CT scans. Under these circumstances, the positive predictive value of a concerning FDG-PET-CT is relatively low especially at 3 months. Introduction/Background: Differentiating local recurrence (LR) from post-treatment changes following stereotactic ablative radiotherapy (SABR) for thoracic tumors is challenging. We sought to evaluate the performance of FDG-PET-CT in distinguishing recurrence from post-radiation changes in patients with stage I-II non???small cell lung cancer (NSCLC) treated with SABR. Materials and Methods: We performed a retrospective review of patients with stage I-II NSCLC treated with SABR and subsequently followed with surveillance FDG-PET-CT scans from 2004 to 2014. The radiology reports were coded as 0 or 1 if minimally or substantially concerning for LR, respectively, and correlated with outcome. Prognostic factors for false-positive FDG-PET-CT were assessed using logistic regression models. Results: We identified 145 patients meeting inclusion cr iter ia for the retrospective analysis. Amongst the 39 (26.9%) patients with FDG-PET-CT scans concerning for LR 3 to 24 months after treatment, 14 were confirmed to have LR. Thus, the positive predictive value (PPV) of FDG-PET-CT in identifying LR was 36% (14/39). Factors associated with a false-positive scan included concerning FDG-PET-CT at the earliest post-treatment time point (3 months) (odds ratio 0.67, P = .04) and older age (odds ratio 2.3, P = .02). Conclusion: Our analysis indicates that the PPV of a concerning FDG-PET-CT after SABR for early-stage NSCLC is relatively low, especially at early post-treatment timepoints, but accuracy is improving over time with institutional experience.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 16 条
[1]   Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].
Aberle, Denise R. ;
Adams, Amanda M. ;
Berg, Christine D. ;
Black, William C. ;
Clapp, Jonathan D. ;
Fagerstrom, Richard M. ;
Gareen, Ilana F. ;
Gatsonis, Constantine ;
Marcus, Pamela M. ;
Sicks, JoRean D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409
[2]   Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC) -: A systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project [J].
Berghmans, Thierry ;
Dusart, Michele ;
Paesmans, Marianne ;
Hossein-Foucher, Claude ;
Buvat, Irene ;
Castaigne, Catherine ;
Scherpereel, Arnaud ;
Mascaux, Celine ;
Moreau, Michel ;
Roelandts, Martine ;
Alard, Stphane ;
Meert, Anne-Pascale ;
Patz, Edward F., Jr. ;
Lafitte, Jean-Jacques ;
Sculier, Jean-Paul .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) :6-12
[3]   A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients [J].
Bollineni, V. R. ;
Kramer, G. M. ;
Jansma, E. P. ;
Liu, Y. ;
Oyen, W. J. G. .
EUROPEAN JOURNAL OF CANCER, 2016, 55 :81-97
[4]   Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Chang, Joe Y. ;
Senan, Suresh ;
Paul, Marinus A. ;
Mehran, Reza J. ;
Louie, Alexander V. ;
Balter, Peter ;
Groen, Harry J. M. ;
McRae, Stephen E. ;
Widder, Joachim ;
Feng, Lei ;
van den Borne, Ben E. E. M. ;
Munsell, Mark F. ;
Hurkmans, Coen ;
Berry, Donald A. ;
van Werkhoven, Erik ;
Kresl, John J. ;
Dingemans, Anne-Marie ;
Dawood, Omar ;
Haasbeek, Cornelis J. A. ;
Carpenter, Larry S. ;
De Jaeger, Katrien ;
Komaki, Ritsuko ;
Slotman, Ben J. ;
Smit, Egbert F. ;
Roth, Jack A. .
LANCET ONCOLOGY, 2015, 16 (06) :630-637
[5]   Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer [J].
Dahele, Max ;
Palma, David ;
Lagerwaard, Frank ;
Slotman, Ben ;
Senan, Suresh .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) :1221-1228
[6]   Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer [J].
Ebright, Michael I. ;
Russo, Gregory A. ;
Gupta, Avneesh ;
Subramaniam, Rathan M. ;
Fernando, Hiran C. ;
Kachnic, Lisa A. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 145 (03) :709-715
[7]   A PILOT TRIAL OF SERIAL 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH MEDICALLY INOPERABLE STAGE I NON-SMALL-CELL LUNG CANCER TREATED WITH HYPOFRACTIONATED STEREOTACTIC BODY RADIOTHERAPY [J].
Henderson, Mark A. ;
Hoopes, David J. ;
Fletcher, James W. ;
Lin, Pei-Fen ;
Tann, Mark ;
Yiannoutsos, Constantin T. ;
Williams, Mark D. ;
Fakiris, Achilles J. ;
McGarry, Ronald C. ;
Timmerman, Robert D. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03) :789-795
[8]   FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study [J].
Hiniker, Susan M. ;
Sodji, Quaovi ;
Quon, Andrew ;
Gutkin, Paulina M. ;
Arksey, Natasha ;
Graves, Edward E. ;
Chin, Frederick T. ;
Maxim, Peter G. ;
Diehn, Maximilian ;
Loo, Billy W., Jr. .
FRONTIERS IN ONCOLOGY, 2019, 9
[9]   FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer [J].
Hoopes, David J. ;
Tann, Mark ;
Fletcher, James W. ;
Forquer, Jeffrey A. ;
Lin, Pei-Fen ;
Lo, Simon S. ;
Timmerman, Robert D. ;
McGarry, Ronald C. .
LUNG CANCER, 2007, 56 (02) :229-234
[10]   Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature [J].
Huang, Kitty ;
Dahele, Max ;
Senan, Suresh ;
Guckenberger, Matthias ;
Rodrigues, George B. ;
Ward, Aaron ;
Boldt, R. Gabriel ;
Palma, David A. .
RADIOTHERAPY AND ONCOLOGY, 2012, 102 (03) :335-342